The effect of R547, a cyclin-dependent kinase inhibitor, on hepatocellular carcinoma cell death
Hepatocellular carcinoma (HCC) is the third main cause of cancer-related death. Cyclin-dependent kinases (CDKs) and their cyclin partners regulate the cell cycle. Since inhibition of CDKs gives some guiding ideas for cancer studies, we aimed to determine the possible effects of R547, a cyclin kinase 1-2-4 inhibitor, on proliferation and apoptotic mechanisms of Hep G2 cells (human) and H-4- II-E cells derived from rat HCC. We determined in vitro survival rates with MTT assay, apoptosis with flow cytometry, morphological changes with confocal microscopy, and ultrastructural changes by transmission electron microscopy. Cisplatin was used as a positive control. After 24 h of culture with 0.1, 1, 10, 50, and 100 ?M doses of R547, the corresponding percentages of live Hep G2 cells were 101%, 94%, 93%, 89%, and 79% (P
___
- Bollard J, Miguela V, Ruiz de Galarreta M, Venkatesh A, Bian CB
et al. (2017). Palbociclib (PD-0332991), a selective CDK4 /
6 inhibitor, restricts tumour growth in preclinical models of
hepatocellular carcinoma. Gut 66 (7): 1286-1296. doi: 10.1136/
gutjnl-2016-312268
- Cho SJ, Lee SS, Kim YJ, Park BD, Choi JS et al. (2010). Xylocydine,
a novel CDK inhibitor, is an effective inducer of apoptosis in
hepatocellular carcinoma cells in vitro and in vivo. Cancer
Letters 287 (2): 196-206. doi: 10.1016/j.canlet.2009.06.011
- De Pinto W, Chu XJ, Xuefeng Y, Smith M, Packman K et al. (2006). In
vitro and in vivo activity of R547: A potent and selective cyclindependent kinase inhibitor currently in phase I clinical trials.
Cancer Therapy 5 (11): 2644-2658. doi: 10.1158/1535-7163
- Doonan F, Cotter TG. (2008). Morphological assessment of apoptosis.
Methods 44 (3): 200-204. doi: 10.1016/j.ymeth.2007.11.006
- Funk JO (2005). Cell Cycle Checkpoint Genes and Cancer.
Encyclopedia of Life Sciences. New York, NY, USA: John Wiley
& Sons, Ltd. doi: 10.1038/npg.els.0006046
- Kang HW, Muramatsu H, Lee BJ, Kwon YS (2010). Monitoring of
anticancer effect of cisplatin and 5-fluorouracil on HepG2
cells by quartz crystal microbalance and micro CCD camera.
Biosensors and Bioelectronics 26 (4): 1576-1581. doi: 10.1016/j.
bios.2010.07.116
- Kishimoto S, Yasuda M, Suzuki R, Fukushima S (2016). Intracellular
uptake of an antitumor-active azole-bridged dinuclear
platinum (II) complex in cisplatin-resistant tumor cells.
Biometals 29 (6): 1075-1083. doi: 10.1007/s10534-016-9978-5
- Mosmann T (1983). Rapid colorimetric assay for cellular growth
and survival: application to proliferation and cytotoxicity
assays. Journal of Immunological Methods 65: 55-63. doi:
10.1016/0022-1759(83)90303-4
- Oztopcu-Vatan P, Sayitoglu M, Gunindi M, Inan E (2015). Cytotoxic
and apoptotic effects of menadione on rat hepatocellular
carcinoma cells. Cytotechnology 67 (6): 1003-1009. doi:
10.1007/s10616-014-9739-7
- Peyressatre M, Prével C, Pellerano M, Morris MC (2015). Targeting
cyclin-dependent kinases in human cancers. Cancers 7 (1):
179-237. doi: 10.3390/cancers7010179
- Sánchez-Martinez C, Gelbert LM, Lallena MJ, Dios A (2015). Cyclin
dependent kinase (CDK) inhibitors as anticancer drugs.
Bioorganic & Medicinal Chemistry Letters 25 (17): 3420-3435.
doi: 10.1016/j.bmcl.2015.05.100
- Shackelford RE, Kaufmann WK, Paules RS (1999). Cell cycle control,
checkpoint mechanisms, and genotoxic stress. Environmental
Health Perspectives 107 (Suppl. 1): 5-24. doi: 10.1289/
ehp.99107s15
- Shi XN, Li H, Yao H, Liu X, Li L et al. (2015) In silico identification
and in vivo validation of anti-psychotic drugs. PLoS One 10
(7): e0132072. doi: 10.1371/journal.pone.0132072
- Sorf A, Novotna E, Hofman J, Morell A (2019) Cyclin-dependent
kinase inhibitors AZD5438 and R547 show potential for
enhancing efficacy of daunorubicin-based anticancer therapy:
Interaction with carbonyl-reducing enzymes and ABC
transporters. Biochemical Pharmacology 163: 290-298. doi:
10.1016/j.bcp.2019.02.035
- Wang F, He L, Dai WQ, Xu YP, Wu D et al. (2012). Salinomycin
inhibits proliferation and induces apoptosis of human
hepatocellular carcinoma cells in vitro and in vivo. PLoS One 7
(12): e50638. doi: 10.1371/journal.pone.0050638
- Xiao J, Qiu P, Lai X, He P, Wu Y et al. (2014). Cyclin-dependent kinase
1 inhibitor RO3306 promotes mitotic slippage in paclitaxeltreated HepG2 cells. Neoplasma 61 (1): 41-47.
Xu MY, Kim YS (2014). Antitumor activity of glycyrol via induction
of cell cycle arrest, apoptosis and defective autophagy.
Food and Chemical Toxicology 74: 311-319. doi: 10.1016/j.
fct.2014.10.023
- Zhang CZ, Zhang H, Yun J, Chen GG, Lai PB (2012).
Dihydroartemisinin exhibits antitumor activity toward
hepatocellular carcinoma in vitro and in vivo. Biochemical
Pharmacology 83 (9): 1278-1289. doi: 10.1016/j.
bcp.2012.02.002
- Zhang JF, Liu JJ, Lu MQ, Cai CJ, Yang Y et al. (2007). Rapamycin
inhibits cell growth by induction of apoptosis on hepatocellular
carcinoma cells in vitro. Transplant Immunology 17 (3): 162-
168. doi: 10.1016/j.trim.2006.12.003